Loading…
Lobbying Spend
$220K
Filings
4
Firms Hired
1
Active Period
2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1414
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1414
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1414
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1414
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1414
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1414
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1414
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2026 · third_quarter · Firm: SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2026 · third_quarter · Firm: SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2026 · third_quarter · Firm: SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2026 · third_quarter · Firm: SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2026 · third_quarter · Firm: SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2026 · third_quarter · Firm: SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2026 · third_quarter · Firm: SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1492
Genomic Answers for Children’s Health Act of 2026
2026 · third_quarter · Firm: SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.7118
Genomic Answers for Children’s Health Act of 2026
2026 · third_quarter · Firm: SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.7118
Genomic Answers for Children’s Health Act of 2026
2026 · third_quarter · Firm: SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.7118
Genomic Answers for Children’s Health Act of 2026
2026 · third_quarter · Firm: SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.7118
Genomic Answers for Children’s Health Act of 2026
2026 · third_quarter · Firm: SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.7118
Genomic Answers for Children’s Health Act of 2026
2026 · third_quarter · Firm: SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.7118
Genomic Answers for Children’s Health Act of 2026
2026 · third_quarter · Firm: SOLENO THERAPEUTICS, INC.
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: H.R.7118
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: S.832
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: S.832
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: S.832
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Client expense: $70,000 · Firm income: —
Matched citations: S.832
Source: Senate LDA